High Expression of PRSS3 Indicates Unfavorable Clinical Outcomes in Colon Adenocarcinoma
Conclusions:
High expression of PRSS3 was significantly related to the unfavorable clinical features and poor prognosis in CAC patients. It suggested that PRSS3 might serve as a novel prognostic indicator and potential drug target for CAC treatment.
Source: Applied Immunohistochemistry and Molecular Morphology - Category: Chemistry Tags: Research Articles Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemistry | Colon Cancer | Colorectal Cancer | Study